MAYNF   $0.122181  -6.67% Market Closed

Mayne Pharma Group Ltd
Total Cash 149.28M
totalCashPerShare 1.837
EBITDA 18.80M
Total Debt 38.82M
quickRatio 1.137
currentRatio 1.467
Total Revenue 388.40M
debtToEquity 8.547
Revenue/Share 4.878
ROA -0.02329
ROE -0.30981
grossProfits
freeCashflow 59.83M
operatingCashflow -15.30M
earningsGrowth
revenueGrowth 0.526
grossMargins 0.56327
ebitdaMargins 0.0484
operatingMargins -0.03293
profitMargins -0.44859
enterpriseValue 153.18M
forwardPE
floatShares 58.98M
sharesOutstanding 85.07M
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.25%
heldPercentInstitutions 0.17%
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue 5.59
Price To Book help_outline 0.58
earningsQuarterlyGrowth
netIncomeToCommon -168.62M
trailingEps -1.47%
forwardEps
enterpriseToEbitda 8.15
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 22
lastUpdated Oct. 16, 2024, 5:35 p.m.